$80.77
-3.65-4.32%
Last update: Nov 11, 12:19 AM
CareDx Inc
CDNANASDAQ
CareDx rose 381.3% from $16.78 to $80.77, ahead of the S&P 500's +9.8%. Its worst day was Nov 5 (−11.1%), and its low came Nov 17 at $15.51.
Nov 11, 2025 – Nov 10, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
CareDx closed at its lowest level of the year, 7.6% below where the year started.
−2.7% · S&P 500 −0.9%
CareDx (NASDAQ:CDNA) sees Q4 sales of $108.000 million vs $102.584 million analyst estimate.
Story events cover the past 12 months · Times ET
+20.1% · S&P 500 +0.2%
EPS of $0.12 missed the $0.23 estimate on $108.4M revenue (est. $102.7M); FY revenue guidance of $420.0M–$444.0M against the $417.5M consensus.
−4.1% · S&P 500 +0.8%
CareDx shares rose 27.6%, while the S&P 500 rose 0.2%.
+27.6% · S&P 500 +0.2%
EPS of $0.34 beat the $0.08 estimate on $117.7M revenue (est. $105.5M); FY revenue guidance of $447.0M–$465.0M against the $439.9M consensus.
−5.1% · S&P 500 0.0%
CareDx shares rose 35.6%, while the S&P 500 fell 0.5%.
+35.6%, the year's best day, on 4M shares, the year's heaviest volume · S&P 500 −0.5%
EPS of $0.37 beat the $0.20 estimate on $131.9M revenue (est. $114.1M); FY revenue guidance of $490.0M–$500.0M against the $455.7M consensus.
+14.7% · S&P 500 +0.7%
CareDx shares rose 13.0%, while the S&P 500 fell 0.1%.
+13.0% · S&P 500 −0.1%
EPS of $0.70 beat the $0.22 estimate on $139.4M revenue (est. $122.0M); FY revenue guidance of $520.0M–$530.0M against the $495.1M consensus.
+22.2% · S&P 500 −1.8%
Where it ended: a close of $80.77 on Nov 10, 2026. Up next: Q4 2026 earnings on Feb 23, 2027 (EPS est. $0.32, revenue est. $135.9M).
Nothing in the past 12 months.
All CDNA dividend historyReplay the year: the line draws itself and stops at each of the 9 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for CDNA and SPY from Benzinga historical bars. Not investment advice.
